VNA
GILD icon

Valley National Advisers’s Gilead Sciences GILD Stock Holding History

Valley National Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.34M Sell
31,177
-903
-3% -$126K 0.56% 34
2025
Q4 		$3.94M Sell
32,080
-642
-2% -$78K 0.55% 31
2025
Q3 		$3.63M Sell
32,722
-631
-2% -$71.7K 0.56% 34
2025
Q2 		$3.7M Sell
33,353
-1,937
-5% -$206K 0.6% 33
2025
Q1 		$3.95M Sell
35,290
-2,803
-7% -$289K 0.71% 25
2024
Q4 		$3.52M Sell
38,093
-9,062
-19% -$816K 0.63% 31
2024
Q3 		$3.95M Sell
47,155
-43,699
-48% -$3.33M 0.71% 27
2024
Q2 		$6.23M Sell
90,854
-7,083
-7% -$473K 0.92% 24
2024
Q1 		$7.17M Sell
97,937
-3,676
-4% -$283K 1.08% 21
2023
Q4 		$8.23M Sell
101,613
-6,073
-6% -$473K 1.31% 17
2023
Q3 		$8.07M Sell
107,686
-6,688
-6% -$514K 1.41% 16
2023
Q2 		$8.82M Sell
114,374
-6,800
-6% -$542K 1.48% 15
2023
Q1 		$10.5M Sell
121,174
-2,042
-2% -$169K 1.85% 9
2022
Q4 		$10.7M Sell
123,216
-2,267
-2% -$180K 1.93% 9
2022
Q3 		$8.39M Buy
125,483
+2,465
+2% +$155K 1.75% 10
2022
Q2 		$7.72M Buy
123,018
+9,624
+8% +$596K 1.63% 13
2022
Q1 		$6.74M Buy
113,394
+39,186
+53% +$2.5M 1.29% 15
2021
Q4 		$5.39M Buy
74,208
+11,926
+19% +$821K 0.99% 18
2021
Q3 		$4.35M Buy
62,282
+8,420
+16% +$592K 0.79% 25
2021
Q2 		$3.71M Buy
53,862
+14,706
+38% +$982K 0.68% 28
2021
Q1 		$2.53M Buy
39,156
+37,874
+2,954% +$2.44M 0.49% 38
2020
Q4 		$75K Sell
1,282
-26
-2% -$1.57K 0.02% 281
2020
Q3 		$83K Hold
1,308
– – 0.02% 248
2020
Q2 		$101K Buy
1,308
+75
+6% +$5.75K 0.02% 221
2020
Q1 		$92K Sell
1,233
-5
-0.4% -$345 0.03% 216
2019
Q4 		$80K Hold
1,238
– – 0.02% 265
2019
Q3 		$78K Sell
1,238
-100
-7% -$6.54K 0.02% 256
2019
Q2 		$90K Sell
1,338
-78
-6% -$5.13K 0.02% 244
2019
Q1 		$92K Sell
1,416
-44
-3% -$2.92K 0.03% 238
2018
Q4 		$91K Sell
1,460
-146
-9% -$10.2K 0.03% 211
2018
Q3 		$124K Sell
1,606
-11
-0.7% -$831 0.04% 197
2018
Q2 		$115K Buy
1,617
+39
+2% +$2.75K 0.04% 200
2018
Q1 		$119K Hold
1,578
– – 0.04% 189
2017
Q4 		$113K Hold
1,578
– – 0.04% 196
2017
Q3 		$128K Sell
1,578
-157
-9% -$12K 0.04% 178
2017
Q2 		$123K Buy
1,735
+1
+0.1% +$67 0.04% 178
2017
Q1 		$118K Sell
1,734
-51
-3% -$3.59K 0.04% 177
2016
Q4 		$128K Buy
1,785
+13
+0.7% +$966 0.06% 170
2016
Q3 		$140K Sell
1,772
-25
-1% -$2.03K 0.07% 146
2016
Q2 		$150K Buy
1,797
+130
+8% +$11.5K 0.08% 148
2016
Q1 		$153K Buy
1,667
+1
+0.1% +$90 0.08% 142
2015
Q4 		$169K Buy
1,666
+1
+0.1% +$104 0.1% 131
2015
Q3 		$164K Buy
1,665
+93
+6% +$10.3K 0.1% 137
2015
Q2 		$184K Sell
1,572
-11
-0.7% -$1.2K 0.1% 137
2015
Q1 		$155K Sell
1,583
-157
-9% -$15.9K 0.09% 138
2014
Q4 		$131K Buy
+1,740
New +$180K 0.1% 118

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Valley National Advisers's GILD Position: Q1 2026 in Review

Valley National Advisers reduced its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, selling an estimated $126K and leaving 31,177 shares worth $4.34M. The position accounts for 0.56% of the portfolio, ranked #34.

Valley National Advisers first reported a position in GILD in Q4 2014 and has held it in 46 quarters since. The position peaked at $10.7M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Valley National Advisers held 31,177 shares of Gilead Sciences worth $4.34M as of Q1 2026.
  • Valley National Advisers sold 903 Gilead Sciences shares in Q1 2026, an estimated $126K.
  • Gilead Sciences made up 0.56% of Valley National Advisers's portfolio in Q1 2026, its #34 holding.
  • Valley National Advisers first reported a position in Gilead Sciences in Q4 2014 and has held it in 46 quarters since.
  • Valley National Advisers's Gilead Sciences position peaked at $10.7M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Valley National Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.